Customer Support Designed to Meet Your Treatment Needs

Professional links

You're one click away from the online nephrology community

Continuing Medical Education (CME)
American Society of Nephrology

Practice Guidelines
National Kidney Foundation Clinical Guidelines
NGC: Kidney Disease
NKF: Published KDOQI Guidelines

Associations
American Kidney Fund
American Nephrology Nurses Association
American Society of Nephrology
American Society of Diagnostic and Interventional Nephrology
American Society of Pediatric Nephrology
International Society of Nephrology
National Kidney Foundation
National Renal Administrators Association
Renal Physicians Association

Additional Information Resources
CyberNephrology
Hypertension, Dialysis, and Clinical Nephrology (HDCN)
Nephrology News & Issues Online
Nephron Information Center
RenalWeb

Patient support links

The following organizations offer information about iron deficiency anemia and kidney disease in English and Spanish

National Kidney Foundation (NKF)

A major voluntary nonprofit health organization dedicated to preventing kidney and urinary tract diseases, improving the health and well-being of individuals and families affected by kidney disease, and increasing the availability of all organs for transplantation.
www.kidney.org
Toll-free number: (800) 622-9010

American Kidney Fund (AKF)

An organization dedicated to fighting kidney disease through direct financial support to patients in need, health education, and prevention efforts.
www.kidneyfund.org
Toll-free number: (800) 638-8299

American Association of Kidney Patients (AAKP)

A national non-profit organization founded by and for kidney patients striving to educate and improve the health and well-being of chronic kidney disease (CKD) patients, those on hemodialysis or peritoneal dialysis, and transplant recipients.
www.aakp.org
Toll-free number: (800) 749-2257

National Kidney Disease and Education Program (NKDEP)

An initiative of the National Institutes of Health designed to reduce the morbidity and mortality caused by kidney disease and its complications.
www.nkdep.nih.gov
Toll-free number: (866) 4-KIDNEY

Renal Support Network

A nonprofit, patient-focused, patient-run organization that provides nonmedical services to those affected by CKD.
www.rsnhope.org
Toll-free number: (866) 903-1728

Important Safety Information for Ferrlecit

Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferrlecit (sodium ferric gluconate) in post marketing experience. Patients may present with shock, clinically significant hypotension, loss of consciousness, or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferrlecit administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferrlecit when personnel and therapies are immediately available for the treatment of anaphylaxis and other hypersensitivity reactions.
  • Ferrlecit is contraindicated in patients with known hypersensitivity to Ferrlecit.
  • Ferrlecit may cause clinically significant hypotension. Administration of Ferrlecit may augment hypotension caused by dialysis and usually resolves within one to two hours. Monitor patients for sign and symptoms of hypotension during and following administration.
  • Do not administer to patients with evidence of iron overload.
  • Ferrlecit contains benzyl alcohol as a preservative. Benzyl alcohol has been associated with serious adverse events and death in pediatric patients. Caution should be exercised when Ferrlecit is administered to a pregnant or nursing woman.
  • The most commonly reported adverse reactions (≥10%):
    • In adult patients were nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps and pain.
    • In patients 6 to 15 years of age the most common adverse reactions (≥10%) were hypotension, headache, hypertension, tachycardia and vomiting.

For more information on Ferrlecit, please see full Prescribing Information.